Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.0B | 7.8B | 6.3B | 7.3B |
Cost of revenue | 3.5B | 4.0B | 3.7B | 3.3B |
Gross profit | 3.5B | 3.7B | 2.7B | 4.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | 0 | — |
Operating income | 1.8B | 2.0B | 1.1B | 2.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 874M | 714M | 693M | 692M |
Other income expense | 252M | 254M | 180M | 236M |
Pretax income | 1.1B | 1.6B | 545M | 1.9B |
Tax provision | 289M | 280M | 79M | 377M |
Net income | 853M | 1.3B | 466M | 1.5B |
Basic EPS | — | 1.2 | 0.5 | 1.4 |
Diluted EPS | — | 1.2 | 0.5 | 1.4 |
Basic average shares | — | 1.1B | 1.1B | 1.1B |
Diluted average shares | — | 1.1B | 1.1B | 1.1B |
EBITDA | 3.4B | 3.6B | 2.5B | 3.9B |
Net income from continuing op. | 853M | 1.3B | 466M | 1.5B |
Minority interests | 27M | 64M | 68M | 0 |
Preferred stock dividends | — | — | — | — |